Health and Medical Guide to Eyes and Vision Eyes and Vision Health information topics about Eyes and Vision: Age-Related Macular Degeneration (Macular Degeneration) AMD (Macular Degeneration) Anatomy (Anatomy) Astigmatism (Refractive Errors) Behcet's Syndrome (Behcet's Syndrome) Blindness (Vision Impairment and Blindness) Cataract (Cataract) Conjunctivitis (Eye Diseases) Contact Lenses (Eye Wear) Diabetic Eye Problems (Diabetic Eye Problems) Eye Cancer (Eye Cancer) Eye Diseases (Eye Diseases) Eye Injuries (Eye Injuries) Eye Wear (Eye Wear) Farsightedness (Refractive Errors) Floater (Retinal Disorders) Glasses (Eye Wear) Glaucoma (Glaucoma) Hyperopia (Refractive Errors) Intraocular Melanoma (Eye Cancer, Melanoma) Laser Eye Surgery (Laser Eye Surgery) LASIK (Laser Eye Surgery) Low Vision (Vision Impairment and Blindness) Macular Degeneration (Macular Degeneration) Myopia (Refractive Errors) Nearsightedness (Refractive Errors) Nystagmus (Eye Diseases) Ophthalmology (Eye Diseases) Pink Eye (Eye Diseases) Protective Eye Wear (Eye Injuries) Refractive Errors (Refractive Errors) Retinal Disorders (Retinal Disorders) Retinoblastoma (Eye Cancer) Strabismus (Eye Diseases) Vision Impairment and Blindness (Vision Impairment and Blindness   Eye Health / Blindness News From Medical News Today Latest Health News and Medical News posted throughout the day, every day. ACT Files Documentation With FDA For Clinical Trials Using ES Cells To Treat ... 29 Jul 2010 at 2:00pm Advanced Cell Technology, Inc... American Academy Of Ophthalmology Wins Award Of Excellence For Haiti Relief E... 29 Jul 2010 at 7:00am The American Academy of Ophthalmology (Academy) is one of only 21 organizations nationally to receive an Award of Excellence for its Task Force on Haiti Recovery work from the ASAE and The Center for Association Leadership as part of their Associations Advance America (AAA) program... Face Recognition Study May Lead To Improved Computer Face Recognition Algorithms 29 Jul 2010 at 5:00am A specific area in our brains is responsible for processing information about human and animal faces, both how we recognize them and how we interpret facial expressions. Now, Tel Aviv University research is exploring what makes this highly specialized part of the brain unique, a first step to finding practical applications for that information. In her "Face Lab" at Tel Aviv University, Dr... When Is It Time For Cataract Surgery? 29 Jul 2010 at 5:00am Almost everyone who lives a long life will develop cataracts at some point. As more Americans live into their 70s and beyond, we all need to know a few cataract basics: risks and symptoms, tips that may delay onset, and how to decide when it is time for surgery, so good vision can be restored... Back-To-School Checklist Should Include Trip To Eye Doctor 29 Jul 2010 at 3:00am Parents and students throughout the country are crossing items off their back-to-school checklists, but most are missing an important task to ensure learning success - a visit to the eye doctor for a comprehensive eye exam. According to an American Optometric Association (AOA) survey of K-12 teachers, 81 percent believe vision and learning are interdependent... Can We Trust What A Model Predicts? 28 Jul 2010 at 5:00am When advanced modeling methods are used to investigate the health economics of complex treatments, efforts must be made to make sure that the model outcomes are reliable. Researchers at the University Eye Clinic in Maastricht developed a model that simulates the lives of glaucoma patients... NEI/FDA To Hold One-Day Glaucoma Endpoints Meeting 28 Jul 2010 at 4:00am The National Eye Institute (NEI) and the Food and Drug Administration (FDA) are sponsoring a Glaucoma Endpoints conference on September 24, 2010, to develop definitions and standards for describing structural changes in the glaucomatous optic nerve and functional changes in vision, as criteria for approval of new glaucoma therapeutics in clinical trials... Omeros Enrolls First Patient In Phase 2b Clinical Trial Evaluating OMS302 In ... 28 Jul 2010 at 4:00am Omeros Corporation (Nasdaq: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced that it has enrolled the first patient in its Phase 2b clinical trial evaluating OMS302 in patients undergoing cataract surgery... Contact Lens Injury Leading Cause Of Medical Device Emergency Visits Among US... 27 Jul 2010 at 4:00am A government report says that contact lens injury is the leading cause of over 70,000 emergency department (ED) visits every year for medical device-associated injury among US children and that more public health initiatives are needed to prevent such easily averted injuries in children, which are often due to wearing lenses for too long and not cleaning them properly... iCo Therapeutics Inc. Receives Health Canada Clearance To Conduct Phase II DM... 27 Jul 2010 at 2:00am iCo Therapeutics Inc. (TSX VENTURE:ICO) is pleased to announce that the Therapeutic Products Directorate, a division of Health Canada, has issued a No Objection Letter response to the Company regarding its iCo-007 Phase II Diabetic Macular Edema (DME) Clinical Trial Application (CTA)... Two Therapies Slow Diabetic Eye Disease Progression 25 Jul 2010 at 2:00am In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans... Ampio Pharmaceuticals Announces Initiation Of Phase II Clinical Trial Of Optina™ 23 Jul 2010 at 5:00am Ampio Pharmaceuticals, Inc. (OTC Bulletin Board: AMPE) announced the initiation of a Phase II clinical trial of Optina™ for the treatment of diabetic macular edema, an early stage of diabetic retinopathy. Diabetic macular edema is responsible for most vision loss in patients with diabetes mellitus... Vision Loss Halted By Valproic Acid In Patients With Retinitis Pigmentosa 23 Jul 2010 at 2:00am Researchers at the University of Massachusetts Medical School (UMMS) believe they may have found a new treatment for retinitis pigmentosa (RP), a severe neurodegenerative disease of the retina that ultimately results in blindness. One of the more common retinal degenerative diseases, RP is caused by the death of photoreceptor cells and affects 1 in 4,000 people in the United States... Hope & Protection Against Blinding Disease Delivered To Millions 21 Jul 2010 at 10:00am This month marks the 150 millionth treatment against river blindness by international development NGO Sightsavers. Since 1987 when pharmaceutical company Merck & Co., Inc... When You Feel Blue, Why Does Everything Look Gray ? 21 Jul 2010 at 5:00am Regardless of culture, language, era, or individual artist, the arts consistently depict depression using darkness. Scientific findings now lend empirical support to this representation of depression that everything looks gray when you feel blue...     HealthBusinessBuilder.com Build your Health Business Fast!